Table 1.
Populationa | Year | Trials | Locations | Linesb | IT 1c | SEV 1d | IT 2 | SEV 2 | IT 3 | SEV 3 |
---|---|---|---|---|---|---|---|---|---|---|
DP | 2013 | 2 | 2 | 475 | X | X | X | X | X | X |
DP | 2014 | 2 | 2 | 474 | X | X | X | X | X | X |
DP | 2015 | 2 | 2 | 474 | X | X | X | X | X | X |
DP | 2016 | 1 | 1 | 474 | X | X | X | X | X | X |
DP | 2013–2014 | 4 | 4 | 475 | X | X | X | X | X | X |
DP | 2013–2015 | 6 | 6 | 475 | X | X | X | X | X | X |
DP | 2013–2016 | 7 | 7 | 475 | X | X | X | X | X | X |
BL | 2016 | 2 | 2 | 304 | X | X | X | |||
BL | 2017 | 4 | 2 | 728 | X | X | X | X | X | X |
BL | 2018 | 3 | 2 | 1,239 | X | X | X | X | X | X |
BL | 2020 | 1 | 1 | 373 | X | X | ||||
BL | 2016–2017 | 6 | 4 | 1,029 | X | X | X | X | X | X |
BL | 2016–2018 | 9 | 6 | 2,262 | X | X | X | X | X | X |
BL | 2016–2020 | 10 | 7 | 2,630 | X | X | X | X | X | X |
DP, Diversity panel; BLs, Breeding lines.
Lines, Unique lines in the training population.
IT, Infection type.
SEV, Disease severity.
X, Indicates measurement recorded.